|
1
|
Raffone A, Travaglino A, Saccone G, Di
Maio A, Mollo A, Mascolo M, De Rosa R, De Placido G, Insabato L and
Zullo F: Diabetes mellitus and responsiveness of endometrial
hyperplasia and early endometrial cancer to conservative treatment.
Gynecol Endocrinol. 35:932–937. 2019. View Article : Google Scholar
|
|
2
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar
|
|
3
|
ENCODE Project Consortium: An integrated
encyclopedia of DNA elements in the human genome. Nature.
489:57–74. 2012. View Article : Google Scholar
|
|
4
|
Zhao X, Tang DY, Zuo X, Zhang TD and Wang
C: Identification of lncRNA-miRNA-mRNA regulatory network
associated with epithelial ovarian cancer cisplatin-resistant. J
Cell Physiol. 234:19886–19894. 2019. View Article : Google Scholar
|
|
5
|
Tang D, Zhao X, Zhang L and Wang C:
Comprehensive analysis of pseudogene HSPB1P1 and its potential
roles in hepatocellular carcinoma. J Cell Physiol. 235:6515–6527.
2020. View Article : Google Scholar
|
|
6
|
Kondo Y, Shinjo K and Katsushima K: Long
non-coding RNAs as an epigenetic regulator in human cancers. Cancer
Sci. 108:1927–1933. 2017. View Article : Google Scholar
|
|
7
|
Li B, Sun H and Zhang J: lncRNA DSCAM-AS1
promotes colorectal cancer progression by acting as a molecular
sponge of miR-384 to modulate AKT3 expression. Aging (Albany NY).
12:9781–9792. 2020. View Article : Google Scholar
|
|
8
|
Qiu Z, Pan XX and You DY: lncRNA DSCAM-AS1
promotes non-small cell lung cancer progression via regulating
miR-577/HMGB1 axis. Neoplasma. 67:871–879. 2020. View Article : Google Scholar
|
|
9
|
Liang WH, Li N, Yuan ZQ, Qian XL and Wang
ZH: DSCAM-AS1 promotes tumor growth of breast cancer by reducing
miR-204-5p and up-regulating RRM2. Mol Carcinog. 58:461–473. 2019.
View Article : Google Scholar
|
|
10
|
Specialized Committee of Gynecological
Tumors of China Anticancer Association, . Guidelines for Diagnosis
and Treatment of Endometrial Cancer (Fourth Edition). Chin J Pract
Gynecol Obstet. 34:880–886. 2018.(In Chinese).
|
|
11
|
Matias-Guiu X and Prat J: Molecular
pathology of endometrial carcinoma. Histopathology. 62:111–123.
2013. View Article : Google Scholar
|
|
12
|
Ryu YJ, Kang SJ, Cho JS, Yoon JH and Park
MH: Lymphovascular invasion can be better than pathologic complete
response to predict prognosis in breast cancer treated with
neoadjuvant chemotherapy. Medicine (Baltimore). 97:e116472018.
View Article : Google Scholar
|
|
13
|
Smith D, Stewart CJR, Clarke EM, Lose F,
Davies C, Armes J, Obermair A, Brennan D, Webb PM, Nagle CM and
Spurdle AB: ER and PR expression and survival after endometrial
cancer. Gynecol Oncol. 148:258–266. 2018. View Article : Google Scholar
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
15
|
Qu Y, Tan HY, Chan YT, Jiang H, Wang N and
Wang D: The functional role of long noncoding RNA in resistance to
anticancer treatment. Ther Adv Med Oncol. 12:17588359209278502020.
View Article : Google Scholar
|
|
16
|
Grixti JM and Ayers D: Long noncoding RNAs
and their link to cancer. Noncoding RNA Res. 5:77–82. 2020.
View Article : Google Scholar
|
|
17
|
Liang J, Zhang S, Wang W, Xu Y, Kawuli A,
Lu J and Xiu X: Long non-coding RNA DSCAM-AS1 contributes to the
tumorigenesis of cervical cancer by targeting miR-877-5p/ATXN7L3
axis. Biosci Rep. 40:BSR201920612020. View Article : Google Scholar
|
|
18
|
Ji D, Hu G, Zhang X, Yu T and Yang J: Long
non-coding RNA DSCAM-AS1 accelerates the progression of
hepatocellular carcinoma via sponging miR-338-3p. Am J Transl Res.
11:4290–4302. 2019.
|
|
19
|
Karreth FA and Pandolfi PP: ceRNA
cross-talk in cancer: When ce-bling rivalries go awry. Cancer
Discov. 3:1113–1121. 2013. View Article : Google Scholar
|
|
20
|
Li J, Huang C, Zou Y, Ye J, Yu J and Gui
Y: CircTLK1 promotes the proliferation and metastasis of renal cell
carcinoma by sponging miR-136-5p. Mol Cancer. 19:1032020.
View Article : Google Scholar
|
|
21
|
Zhao J, Yang T and Li L: lncRNA FOXP4-AS1
is involved in cervical cancer progression via regulating
miR-136-5p/CBX4 axis. Onco Targets Ther. 13:2347–2355. 2020.
View Article : Google Scholar
|
|
22
|
Yang XL, Hao YJ, Wang B, Gu XL, Wang XX
and Sun JF: Long noncoding RNA NORAD promotes the progression of
retinoblastoma by sponging miR-136-5p/PBX3 axis. Eur Rev Med
Pharmacol Sci. 24:40552020.
|
|
23
|
Han C, Fu Y, Zeng N, Yin J and Li Q:
lncRNA FAM83H-AS1 promotes triple-negative breast cancer
progression by regulating the miR-136-5p/metadherin axis. Aging
(Albany NY). 12:3594–3616. 2020. View Article : Google Scholar
|
